[{"Assets_0_Q2_USD":253155000.0,"CommonStockSharesOutstanding_0_Q2_shares":32596000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-25677000.0,"NetIncomeLoss_1_Q2_USD":-4674000.0,"NetIncomeLoss_2_Q2_USD":-17702000.0,"StockholdersEquity_0_Q2_USD":108495000.0,"Ticker":"JNCE","CIK":"1640455","name":"JOUNCE THERAPEUTICS, INC.","OfficialName":"Jounce Therapeutics Inc. Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"354419760.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180809"}]